Wegovy® (semaglutide 2.4mg) by Novo Nordisk is now Available in Singapore for Weight Management
Wegovy® (semaglutide 2.4mg) is a once-weekly injectable treatment indicated for chronic weight management in adults and adolescents (aged 12 and above) living with obesity (BMI ≥30 kg/m²), or who are overweight (BMI ≥27 kg/m² to <30 kg/m²) with at least one weight-related condition such as hypertension, type 2 diabetes, or dyslipidemia1. It is used alongside a reduced-calorie diet and increased physical activity, supporting Singapore's efforts to improve population health.
The treatment works by addressing one of the underlying biological drivers of obesity. Wegovy® (semaglutide 2.4mg) is a GLP-1 receptor agonist with 94% similarity to the body's natural GLP-1 hormone. It activates receptors involved in appetite regulation, helping individuals feel full sooner and reduce food intake1. This mechanism supports weight loss when combined with sustainable lifestyle changes.
The availability of Wegovy® (semaglutide 2.4mg) comes as obesity continues to pose a significant health burden in Singapore. An estimated 600,000 adults are currently living with obesity2-4, a condition associated with more than 200 health complications5. Despite its prevalence and medical complexity, obesity remains heavily stigmatised—often misunderstood as merely the result of poor personal choices. Individuals living with obesity frequently face discrimination and mental health challenges which further isolate them. This misplaced blame, rather than targeting the disease itself, creates barriers to and slows the advancement of effective obesity treatment. Recognised by World Health Organization as a chronic disease6, obesity requires compassionate evidence-based care. The launch of Wegovy® (semaglutide 2.4mg) in Singapore provides a new treatment option for weight management available through private prescription.
Dr Abel Soh, Abel Soh Diabetes, Thyroid and Endocrine Clinic and Chairperson for Endocrine and Metabolic Society of Singapore (EMSS) stated, 'Obesity is not simply the result of lifestyle choices — it is a medically recognised chronic disease influenced by a complex interplay of genetics, hormones, and environment. In my clinical practice, I see firsthand how many individuals blame themselves when in fact, their biology is often working against them. It's time we shift the conversation from blame to support in the management of individuals with obesity'
Lifestyle factors in Singapore further contribute to the challenge. In Singapore's demanding work culture—where full-time employees work an average of 44.6 hours per week7, with time constraints and fatigue frequently cited as barriers to maintaining regular physical activity. These circumstances underscore the importance of comprehensive treatment strategies that facilitate the adoption of healthier lifestyles, including increased physical activity and a reduced-calorie diet, as integral components of long-term weight management.
Mr Vincent Siow, General Manager, Novo Nordisk Singapore, said 'With treatments like Wegovy® (semaglutide 2.4mg) now available in Singapore, we have an opportunity to provide healthcare professionals with more evidence-based options to support their patients in regaining control of their health and improving long-term outcomes.'
References: Wegovy Singapore Prescribing Information, February 2025Cuciureanu M, Caratașu CC, Gabrielian L, Frăsinariu OE, Checheriță LE, Trandafir LM, Stanciu GD, Szilagyi A, Pogonea I, Bordeianu G, Soroceanu RP, Andrițoiu CV, Anghel MM, Munteanu D, Cernescu IT, Tamba BI. 360-Degree Perspectives on Obesity. Medicina (Kaunas). 2023 Jun 9;59(6):1119. doi: 10.3390/medicina59061119. PMID: 37374323; PMCID: PMC10304508.World Obesity. Retrieved from https://www.worldobesity.org/about/about-obesity/prevalence-of-obesity World Obesity. Retrieved from https://data.worldobesity.org/country/singapore-192/Scott I. Kahan, MD, MPH. Practical Strategies for Engaging Individuals With Obesity in Primary Care. Mayo Clin Proc. 2018;93(3):351-359 2. CDC, Cancers Associated with Overweight and Obesity Makeup 40 percent of Cancers Diagnosed in the United States. Available at https://www.cdc.gov/media/releases/2017/p1003-vs-cancer-obesity.html.World Health Organization. (2024). Obesity and overweight.WHO.https://www.who.int/news-room/factsheets/detail/obesity-and-overweight As accessed on 22nd May 2025.Leu J, Rebello SA, Sargent GM, Kelly M, Banwell C. Hard work, long hours, and Singaporean young adults' health. A qualitative study. Frontiers in Public Health. 2023; 11. https://doi.org/10.3389/fpubh.2023.1082581
Hashtag: #NovoNordisk #Wegovy
The issuer is solely responsible for the content of this announcement.
About Novo Nordisk
Novo Nordisk is a leading global healthcare company founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat serious chronic diseases built upon our heritage in diabetes. We do so by pioneering scientific breakthroughs, expanding access to our medicines, and working to prevent and ultimately cure disease. Novo Nordisk employs around 77,400 people in 80 countries and markets its products in around 170 countries. In Singapore, Novo Nordisk has been present since 1997 and has approximately 100 employees.
For more information, visit novonordisk.sg.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 hours ago
- Yahoo
Trump's attorney general drops fraud case tied to COVID vaccinations
WASHINGTON (Reuters) -U.S. Attorney General Pam Bondi on Saturday dropped a case against a Utah doctor accused of falsifying COVID-19 vaccination certificates and destroying more than $28,000 worth of government-provided COVID-19 vaccines. Bondi, in a statement posted on X, said Michael Kirk Moore Jr., of Salt Lake County, Utah did not deserve the jail time he was facing. Moore was indicted by a federal grand jury in 2023 and his trial had begun earlier this month. "Dr. Moore gave his patients a choice when the federal government refused to do so. He did not deserve the years in prison he was facing. It ends today," Bondi said. COVID-19 vaccine skeptics have been embraced by the Trump administration. The Pentagon, for example, has sought to re-enlist servicemembers who were ousted for refusing to be vaccinated during the pandemic. Health Secretary Robert F. Kennedy Jr., who for decades has sown doubt about the safety of vaccines contrary to evidence and research by scientists, wrote on X in April: "Dr. Moore deserves a medal for his courage and his commitment to healing!" According to a 2023 statement from the U.S. Attorney's Office in Utah, Moore allegedly ran the false certifications out of a plastic surgery center. His activities allegedly included administering saline shots to minors, at the request of their parents, so the children would think they were receiving COVID-19 vaccines, the statement said. Marjorie Taylor Greene, a U.S. lawmaker from Georgia and staunch Trump supporter, had championed dropping the case against Moore, who she called a hero in a statement on Saturday. "We can never again allow our government to turn tyrannical under our watch," she said in a post on X. The latest move by Bondi comes amid scrutiny of her firings of senior Justice Department officials who worked on investigations into Trump, stoking accusations of political retribution in a department whose mission is to enforce U.S. laws.
Yahoo
3 hours ago
- Yahoo
UnitedHealth Group Incorporated (UNH): 'Medicare Fraud Is Prison,' Warns Jim Cramer
We recently published . UnitedHealth Group Incorporated (NYSE:UNH) is one of the stocks Jim Cramer recently discussed. UnitedHealth Group Incorporated (NYSE:UNH) is the largest healthcare benefits provider in America. It is also one of the worst-performing stocks in 2025 as the shares have lost 40% year-to-date. UnitedHealth Group Incorporated (NYSE:UNH)'s shares sank by a massive 27.3% in April after the firm stunned investors by missing analyst estimates for its latest quarter. Cramer's recent remarks about the firm discussed media reports of impropriety and pointed out that UnitedHealth Group Incorporated (NYSE:UNH) wouldn't be buying shares if they were true. However, this time, he had a much darker tone: '[On a WSJ report that UNH deploys doctors and nurses to gather diagnoses that bolster its payments with UNH responding that it welcomes reviews] Well I'm glad they welcome it but I do want to caution them, and I think I happen to like this CEO very much, but Medicare fraud is prison. It's not, hey listen we'll slap UNH on the wrist. It's prison. And it's probably the most I think easily, the crimes are easily followed and the judgement is swift. The reason why people are so focused on this is that it's not a fine.' Previously, the CNBC host discussed UnitedHealth Group Incorporated (NYSE:UNH) in detail: 'The third worst performer was, wow, UnitedHealth Group, suddenly very troubled managed care company that used to be the ultimate darling in the group. It's down 38% in the first half. UnitedHealth's troubles are very well documented. I'm not even talking about the assassination last December, as terrible as that was. The real trouble started in April when the company reported a weak quarter, dragged down by high utilization rates, meaning people are getting much more healthcare than UNH… needs to pay for. A senior healthcare professional giving advice to a patient in a clinic. What's starting to become clear is that the company made some major missteps with its underwriting, especially with Medicare Advantage plans for seniors. They're far from the only one in the industry with this problem, but UNH might be the hardest hit. This is the largest player in the Medicare Advantage space with the most extensive data, and they really should have been able to avoid these mistakes. They almost always have, but clearly, they didn't. The company made a change in the top mid-May with CEO Andrew Witty stepping down for personal reasons. Turning around UNH is now the job of Stephen Hemsley, whom I really like. He was previously CEO from 2006 to 2017. And there's some nascent optimism that he can get this business back on track, but I don't necessarily think this will happen quickly. If you're inclined to bet on a UNH comeback, I suggest that you take it slowly because you got all the time in the world. You actually might even want to wait to see the next quarter, which could be what we call a clearing event for the negatives.' While we acknowledge the potential of UNH as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the . READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey.
Yahoo
3 hours ago
- Yahoo
My 11-Year-Old Patient Was Pregnant. Here's What I Want You To Know About Being 'Pro-Life.'
Editor's note: This story was originally published in 2022. In light of new discussions and developments related to reproductive rights, HuffPost Personal is resharing it. One morning this past December, I woke up early to listen to judges with lifetime appointments question lawyers in a process that may ultimately rob people of their reproductive freedom. And week after week since then, I continue to hear judges and lawyers and politicians speak on issues they have no business speaking on ― as far away from people and their real lives as voices from another planet. During these moments, I think of a little girl in an exam room I met many years ago. She was my patient. She was 11. We will call her Sophia. It was my first year in practice doing bread-and-butter primary care. Sophia's mom had brought her in for stomach pain. When I got to her menstrual history, her mom said Sophia had gotten her period but then it had stopped. I reassured her and said sometimes at the start of menstruation, there can be some irregularity and that is not uncommon at all. The mother then left the room and it was just me and Sophia. She was quiet and soft-spoken — a par-for-the-course, awkward adolescent who was uncomfortable interacting with an adult. She answered my questions with one-word responses and didn't quite know where to look. When I left the room, I heard the booming voice in my head of an ER doctor who had trained me: 'Don't be the ass who doesn't order the pregnancy test.' This was one of her clinical teaching pearls: Many young docs will order the blood tests, the ultrasound, the CT scans, but skip the most obvious, most basic test and spend tens of thousands of dollars to work up a patient when the 'diagnosis' is actually pregnancy. Hence, don't be the ass who doesn't order the pregnancy test. So I ordered it. A few minutes later, our medical assistant came to me, panicked, and handed me a positive test. 'Run it again,' I asked her, agape. She ran it again. Positive. 'Run it again,' I sputtered — to buy some time and gather my wits and hope by some miracle it would produce a different result. Positive. She was my patient. She was 11. She was pregnant. I sat Sophia's mom down in another room and quietly explained to her that the pregnancy test came back positive. She didn't understand. I had to repeat myself multiple times in various ways for her to comprehend that Sophia was pregnant. Shock, tears, a cellphone call. Soon a breathless dad showed up, followed by a somber family priest, and then the cops. I remember the adults weeping in a prayer circle in a separate room and the feeling of watching a nightmare unfold, and I had to remind myself that, sometimes, the job is bearing witness to the worst day of someone's life. I tried in vain to coax the truth of what happened out of Sophia, sitting next to her with a large anatomy atlas flipped open in my lap. She said nothing. I was thankful there was a female police officer that was among the throng at the clinic. It was this officer, when permitted to speak with Sophia, who discovered the identity of the family member that did this awful, unspeakable thing to her. And when the cops left to arrest that relative, they headed to church, because the perpetrator was at choir practice. I recall my focus ― my clear understanding that my only job was to ensure that I was there to protect my patient. That whatever happened, my job was to make sure that at every moment, Sophia was centered, and her mental and physical health were the priority. To make sure that she could find her way, in the midst of this trauma and unspeakable crime, and that her precious life was protected. And part of that included a pregnancy termination. We would make certain she had access to it and was able to get it immediately. There was no question that Sophia's life mattered and it mattering meant that she would not be forced to give birth at age 11. And she wasn't. I think about Sophia all the time, especially these days. I think about all the Sophias in clinics like mine, as abortion protections are struck down in state after state ― protections falling like wicked dominoes. I think about the words 'except in cases of the life of the mother.' The choice made that evening of the awful revelation was for the life of the mother. A mother that should have never been and thankfully wasn't. And though it might be easier to build consensus around abortion access for an 11-year-old raped by a family member, the truth is that nobody, anywhere, under any circumstance or in any situation should be forced to give birth. Forced birth should never be a reality. Sophia is in her 20s now. I wonder how she has healed, how she has processed that trauma. Did she get to go to college? Has she been able to trust an intimate partner? Has she been pregnant on her own terms at the time of her choosing? Does she have a child? I can see her wide face and her soft smile in my mind's eye and I know now, just as I knew then, that the decision to terminate Sophia's pregnancy, supported by the ones who loved her the most, was a pro-life decision. One of the things my mind conjures up from that horrible day is the feeling that the clinic was crowded. There was Sophia, her mom, then her dad and the priest, and later the cops. There was the crying and the praying and the disbelieving and the believing. I remember how small Sophia looked. Her small face and her small hands and her small hips and how this big, awful thing could happen to someone so small took the wind out of the place. I remember how tiny that clinic room felt. There was no room for politicians signing evil bills flanked by child props as old as Sophia, no room for Supreme Court justices who claim to value life while wondering aloud how pregnancy can be an undue burden. No room for those extraneous, unnecessary, useless others in that most intimate of spaces. Our clinic rooms will always be too small for anybody but providers and our patients. And we will fight for this sacred space, fight for it to be free of cynical politicians and their divisive games. They have never been invited in and we are not about to sit back or stand by while they force their way in. Note: Names and specific details have been changed to protect the privacy and safety of individuals mentioned in this essay. Dipti S. Barot is a primary care doctor and freelance writer in the San Francisco Bay Area. You can follow her on Twitter at @diptisbarot. This article originally appeared on HuffPost in July 2024. Also in Goodful: Also in Goodful: Also in Goodful:
